Pyroptosis is considered one of a critical factor in the recovery of neurological function following traumatic brain injury. Brain injury activates a molecular signaling cascade associated with pyroptosis and inflammation, including NLRP3, inflammatory cytokines, caspase-1, gasdermin D (GSDMD), and other pyroptosis-related proteins. In this study, we explored the neuroprotective effects of LDC7559, a GSDMD inhibitor. Briefly, LDC7559, siRNA-GSDMD (si-GSDMD), or equal solvent was administrated to mice with a lipopolysaccharide + nigericin (LPS + Nig) model in vitro or with controlled cortical impact brain injury. The findings revealed that inflammation and pyroptosis levels were decreased by LDC7559 or si-GSDMD treatment both in vitro and in vivo. Immunofluorescence staining, brain water content, hematoxylin and eosin staining, and behavioral investigations suggested that LDC7559 or si-GSDMD inhibited microglial proliferation, ameliorated cerebral edema, reduced brain tissue loss, and promoted brain function recovery. Taken together, LDC7559 may inhibit pyroptosis and reduce inflammation by inhibiting GSDMD, thereby promoting the recovery of neurological function.
Get full access to this article
View all access options for this article.
References
1.
DewanM, RattaniA, GuptaS, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg 2018;1–18; doi: 10.3171/2017.10.Jns17352.
2.
PavlovicD, PekicS, StojanovicM, et al.Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae. Pituitary, 2019; 22(3):270–282; doi: 10.1007/s11102-019-00957-9.
3.
VaishnaviS, RaoV, FannJ. Neuropsychiatric problems after traumatic brain injury: unraveling the silent epidemic. Psychosomatics, 2009; 50(3):198–205; doi: 10.1176/appi.psy.50.3.198.
4.
RakhitS, NordnessMF, LombardoSR, et al.Management and challenges of severe traumatic brain injury. Semin Respir Crit Care Med, 2021; 42(1):127–144; doi: 10.1055/s-0040-1716493.
5.
GardnerA, ShihS, AdamovE, et al.Research frontiers in traumatic brain injury: defining the injury. Phys Med Rehab Clin N Am, 2017; 28(2):413–431; doi: 10.1016/j.pmr.2016.12.014.
6.
BroussardJI, AcionL, De Jesús-CortésH, et al.Repeated mild traumatic brain injury produces neuroinflammation, anxiety-like behaviour and impaired spatial memory in mice. Brain Inj, 2018; 32(1):113–122; doi: 10.1080/02699052.2017.1380228.
7.
VoloviciV, ErcoleA, CiterioG, et al.Variation in guideline implementation and adherence regarding severe traumatic brain injury treatment: A CENTER-TBI survey study in Europe. World Neurosurg, 2019; 125:e515–e520; doi: 10.1016/j.wneu.2019.01.116.
8.
RouleauN, BonzanniM, Erndt-MarinoJ, et al. A 3D tissue model of traumatic brain injury with excitotoxicity that is inhibited by chronic exposure to gabapentinoids. Biomolecules 2020;10(8); doi: 10.3390/biom10081196.
9.
BernierL-P, YorkEM, MacVicarBA. Immunometabolism in the brain: how metabolism shapes microglial function. Trends Neurosci, 2020; 43(11):854–869; doi: https://doi.org/10.1016/j.tins.2020.08.008.
10.
RahimifardM, MaqboolF, Moeini-NodehS, et al. Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation. Ageing Res Rev 2017;36(11–19); doi: 10.1016/j.arr.2017.02.004.
11.
SunZ, NyanzuM, YangS, et al. κVX765 attenuates pyroptosis and HMGB1/TLR4/NF-B pathways to improve functional outcomes in TBI mice. Oxid Med Cell Longev 2020;2020(7879629); doi: 10.1155/2020/7879629.
12.
SimonD, McGeachyM, BayırH, et al.The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol, 2017; 13(3):171–191; doi: 10.1038/nrneurol.2017.13.
13.
SpelL, MartinonF. Gasdermin D opens the way for NETs. Nat Rev Rheumatol, 2018; 14(12):690–692; doi: 10.1038/s41584-018-0124-3.
14.
HsuC, HuangC, ChienL, et al.Ischemia/reperfusion injured intestinal epithelial cells cause cortical neuron death by releasing exosomal microRNAs associated with apoptosis, necroptosis, and pyroptosis. Sci Rep, 2020; 10(1):14409; doi: 10.1038/s41598-020-71310-5.
15.
JorgensenI, MiaoE. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev, 2015; 265(1):130–142; doi: 10.1111/imr.12287.
16.
BergsbakenT, FinkS, CooksonB. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol, 2009; 7(2):99–109; doi: 10.1038/nrmicro2070.
17.
HumphriesF, Shmuel-GaliaL, Ketelut-CarneiroN, et al.Succination inactivates gasdermin D and blocks pyroptosis. Science, 2020; 369(6511):1633–1637; doi: 10.1126/science.abb9818.
18.
LiuX, ZhangZ, RuanJ, et al.Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature, 2016; 535(7610):153–158; doi: 10.1038/nature18629.
19.
MortezaeeK, KhanlarkhaniN, BeyerC, et al.Inflammasome: its role in traumatic brain and spinal cord injury. J Cell Physiol, 2018; 233(7):5160–5169; doi: 10.1002/jcp.26287.
20.
WangK, SunQ, ZhongX, et al.Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis. Cell, 2020; 180(5):941–955.e20; doi: 10.1016/j.cell.2020.02.002.
21.
HuX, ChenH, XuH, et al.Role of pyroptosis in traumatic brain and spinal cord injuries. Int J Biol Sci, 2020; 16(12):2042–2050; doi: 10.7150/ijbs.45467.
22.
DanielskiLG, GiustinaAD, BonfanteS, et al.NLRP3 activation contributes to acute brain damage leading to memory impairment in sepsis-surviving rats. Mol Neurobiol, 2020; 57(12):5247–5262; doi: 10.1007/s12035-020-02089-9.
23.
DingJ, WangK, LiuW, et al.Pore-forming activity and structural autoinhibition of the gasdermin family. Nature, 2016; 535(7610):111–116; doi: 10.1038/nature18590.
Rodríguez-GómezJ, KavanaghE, Engskog-VlachosP, et al. Microglia: agents of the CNS pro-inflammatory response. Cells 2020;9(7); doi: 10.3390/cells9071717.
28.
DoH, BuiB, SimS, et al. Anti-inflammatory and anti-migratory activities of isoquinoline-1-carboxamide derivatives in LPS-treated BV2 microglial cells via inhibition of MAPKs/NF-κB pathway. Int J Mol Sci 2020;21(7); doi: 10.3390/ijms21072319.
29.
SchindlerC, LustenbergerT, WoschekM, et al. Severe traumatic brain injury (TBI) modulates the kinetic profile of the inflammatory response of markers for neuronal damage. J Clin Med 2020;9(6); doi: 10.3390/jcm9061667.
30.
SollbergerG, ChoidasA, BurnGL, et al. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Sci Immunol 2018;3(26); doi: 10.1126/sciimmunol.aar6689.
31.
PandeyaA, LiL, LiZ, et al.Gasdermin D (GSDMD) as a new target for the treatment of infection. Medchemcomm, 2019; 10(5):660–667; doi: 10.1039/c9md00059c.
32.
LiuZ, YaoX, JiangW, et al.Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-κB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuroinflammation, 2020; 17(1):90; doi: 10.1186/s12974-020-01751-2.
33.
LiuW, ChenY, MengJ, et al.Ablation of caspase-1 protects against TBI-induced pyroptosis in vitro and in vivo. J Neuroinflammation, 2018; 15(1):48; doi: 10.1186/s12974-018-1083-y.
34.
WuK, HuangD, ZhuC, et al.NT3 gene-modified bone mesenchymal stem cells improve neurological function recovery in mouse TBI model. Stem Cell Res Ther, 2019; 10(1):311; doi: 10.1186/s13287-019-1428-1.
35.
SalvadorE, BurekM, FörsterC. Stretch and/or oxygen glucose deprivation (OGD) in an in vitro traumatic brain injury (TBI) model induces calcium alteration and inflammatory cascade. Front Cell Neurosci 2015;9(323); doi: 10.3389/fncel.2015.00323.
36.
DengY, JiangX, DengX, et al.Pioglitazone ameliorates neuronal damage after traumatic brain injury via the PPARγ/NF-κB/IL-6 signaling pathway. Genes Dis, 2020; 7(2):253–265; doi: 10.1016/j.gendis.2019.05.002.
37.
BaoH, WangT, ZhangM, et al.Poloxamer-188 attenuates TBI-induced blood-brain barrier damage leading to decreased brain edema and reduced cellular death. Neurochem Res, 2012; 37(12):2856–2567; doi: 10.1007/s11064-012-0880-4.
38.
GenétG, BentzerP, OstrowskiS, et al.Resuscitation with pooled and pathogen-reduced plasma attenuates the increase in brain water content following traumatic brain injury and hemorrhagic shock in rats. J Neurotrauma, 2017; 34(5):1054–1062; doi: 10.1089/neu.2016.4574.
39.
HuangC, SakryD, MenzelL, et al.Lack of NG2 exacerbates neurological outcome and modulates glial responses after traumatic brain injury. Glia, 2016; 64(4):507–523; doi: 10.1002/glia.22944.
40.
PöttkerB, StöberF, HummelR, et al.Traumatic brain injury causes long-term behavioral changes related to region-specific increases of cerebral blood flow. Brain Struct Funct, 2017; 222(9):4005–4021; doi: 10.1007/s00429-017-1452-9.
41.
Kruk-SłomkaM, MichalakA, BudzyńskaB, et al.A comparison of mecamylamine and bupropion effects on memory-related responses induced by nicotine and scopolamine in the novel object recognition test in mice. Pharmacol Reports, 2014; 66(4):638–646; doi: 10.1016/j.pharep.2014.02.002.
42.
MuhaV, WilliamsonR, HillsR, et al.Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice. Open Biol, 2019; 9(11):190192; doi: 10.1098/rsob.190192.
43.
AntunesM, BialaG. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process, 2012; 13(2):93–110; doi: 10.1007/s10339-011-0430-z.
44.
GlassT, ReevesB, SharpF. The impact of excitotoxic blockade on the evolution of injury following combined mechanical and hypoxic insults in primary rat neuronal culture. Neurobiol Dis, 2004; 17(3):378–84; doi: 10.1016/j.nbd.2004.07.017.
45.
WangK, SunZ, RuJ, et al. Ablation of GSDMD improves outcome of ischemic stroke through blocking canonical and non-canonical inflammasomes dependent pyroptosis in microglia. Front Neurol 2020;11(577927); doi: 10.3389/fneur.2020.577927.
46.
LeeS, de Rivero VaccariJ, TruettnerJ, et al.The role of microglial inflammasome activation in pyroptotic cell death following penetrating traumatic brain injury. J Neuroinflammation, 2019; 16(1):27; doi: 10.1186/s12974-019-1423-6.
47.
KuwarR, RolfeA, DiL, et al.A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury. J Neuroinflammation, 2019; 16(1):81; doi: 10.1186/s12974-019-1471-y.
48.
VoetS, Mc GuireC, HagemeyerN, et al.A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation. Nature Comm, 2018; 9(1):2036; doi: 10.1038/s41467-018-04376-5.
49.
KoselnyK, MutluN, MinardA, et al. A genome-wide screen of deletion mutants in the filamentous saccharomyces cerevisiae background identifies ergosterol as a direct trigger of macrophage pyroptosis. mBio 2018;9(4); doi: 10.1128/mBio.01204-18.
50.
SantosJ, DickM, LagrangeB, et al. LPS targets host guanylate-binding proteins to the bacterial outer membrane for non-canonical inflammasome activation. EMBO J 2018;37(6); doi: 10.1525/2/embj.201798089.
51.
AlbalawiF, LuW, BeckelJ, et al. The P2X7 receptor primes IL-1β and the NLRP3 inflammasome in astrocytes exposed to mechanical strain. Front Cell Neurosci 2017;11(227); doi: 10.3389/fncel.2017.00227.
52.
HeW, WanH, HuL, et al.Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res, 2015; 25(12):1285–1298; doi: 10.1038/cr.2015.139.
53.
GarlandaC, DinarelloCA, MantovaniA. The interleukin-1 family: back to the future. Immunity, 2013; 39(6):1003–1018; doi: 10.1016/j.immuni.2013.11.010.
54.
EvavoldCL, RuanJ, TanY, et al.The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity, 2018; 48(1):35–44.e6; doi: 10.1016/j.immuni.2017.11.013.
55.
MonteleoneM, StanleyAC, ChenKW, et al.Interleukin-1β maturation triggers its relocation to the plasma membrane for gasdermin-D-dependent and -independent secretion. Cell Rep, 2018; 24(6):1425–1433; doi: 10.1016/j.celrep.2018.07.027.
56.
TaabazuingC, OkondoM, BachovchinD. Pyroptosis and apoptosis pathways engage in bidirectional crosstalk in monocytes and macrophages. Cell Chem Biol 2017;24(4):507.e4–514.e4; doi: 10.1016/j.chembiol.2017.03.009.
57.
OkondoM, JohnsonD, SridharanR, et al.DPP8 and DPP9 inhibition induces pro-caspase-1-dependent monocyte and macrophage pyroptosis. Nature Chem Biol, 2017; 13(1):46–53; doi: 10.1038/nchembio.2229.
58.
ThalS, NeuhausW. The blood-brain barrier as a target in traumatic brain injury treatment. Arch Med Res, 2014; 45(8):698–710; doi: 10.1016/j.arcmed.2014.11.006.
59.
PriceL, WilsonC, GrantG. Blood–Brain Barrier Pathophysiology following Traumatic Brain Injury. In: Translational Research in Traumatic Brain Injury. CRC Press/Taylor and Francis Group: Boca Raton, FL; 2015; pp. 85–96.
60.
CashA, TheusMH. Mechanisms of blood-brain barrier dysfunction in traumatic brain injury. Int J Mol Sci 2020;21(9); doi: 10.3390/ijms21093344.
61.
AmaraN, CooperMP, VoronkovaMA, et al. Selective activation of PFKL suppresses the phagocytic oxidative burst. Cell 2021;184(17):4480.e15–4494.e15; doi: 10.1016/j.cell.2021.07.004.
62.
RabuffettiM, ScioratiC, TarozzoG, et al.Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J Neurosci, 2000; 20(12):4398–404; doi: 10.1523/jneurosci.20-12-04398.2000.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
